ACHE and Alzheimer disease: Kaempferol modulates the antiepileptic target synaptic vesicle transporter 2A (SV2A) [192], inhibits 5-HT 3A receptors [193] involved in memory and cognitive functions, and blocks acetylcholinesterase (AChE) [194] implicated in cognitive dysfunction and memory loss associated with AD.